From 9 Takeaways from Boston’s Life Science Disruptors:

Disruptors, Exter and Leschly

Disruptors, Exter and Leschly—

Neil Exter and Nick Leschly discussing the history of Bluebird Bio.

Underwriters and Partners

Xconomy Insight

From Our Editors · Podcast
Xcelerating Life Sciences Boston: The Highlights Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Sponsored · Webinar
The Need for Manufacturing Execution Systems (MES) in Cell and Gene Therapy
A discussion on business drivers, technical considerations, special requirements of cell and gene product manufacturing & digitization strategy
Global OT/IT Quality Services

Xconomy on Demand

We offer a number of ways to subscribe for free!